Stem Cell Therapies Market - 330 Pipeline Products, yet Commercial Challenges Prevail

Aug 04, 2016, 06:00 ET from RnR Market Research

PUNE, India, August 4, 2016 /PRNewswire/ -- adds "Stem Cell Therapies - Global Trends in the Competitive, Technological and R&D Landscape" 2016 market research report to its store providing an in-depth assessment of the current trends in the global stem cell therapy sector with a particular focus on the technological, competitive and R&D landscape. Along with extensive secondary research efforts, a targeted industry survey of experts and key opinion leaders in the stem cell therapies field was taken to gather opinions on the global trends and future commercial prospects of the stem cell therapies market. The findings from the reviewed literature were measured against the results of the industry survey, and internal research, to provide an objective view of the market that is comprehensive in outlook.

Complete report on Global Stem Cell Therapies Market with 14 Chapters and 17 figures, spread across 46 pages is available at .

While steady progress in clinical research and increasing evidence of product effectiveness are significant driving factors for growth in the stem cell therapies market, a number of obstacles remain before they become widely commercially viable. The stem cell therapy pipeline as a whole is relatively large, with 330 products in active development across all stages. Indeed, R&D within the sector is gaining momentum as candidates move into clinical development, and the results of clinical studies become apparent, clarifying the therapeutic potential of stem cell therapy. The stem cell therapies market space provides therapeutic potential in indications where current pharmacological and surgical treatment options are ineffective. However, there remains a significant divide between the number of stem cell therapeutic applications currently available for patients and the number of research programs investigating the wider medical applications of stem-cell-based therapies.

Stem cells are currently being used for a modest variety of indications, with skin and blood stem cells representing the majority of therapeutic uses. The stem cell industry is pursuing a broad base of therapeutic applications, and this is evident in the R&D efforts observed in the sector, as over 15 stem cell therapies market areas are being targeted by the stem cell industry in over 1,000 clinical trials. Manufacturers will need to adopt novel strategies to realize their full potential. It is likely that manufacturing methodologies will use partially or fully automated systems in future approaches, in order to improve yield, purity and cost-effectiveness. There have been good strides made by stem cell therapies market manufacturing companies, such as those made by Cynata Therapeutics, which is implementing innovative manufacturing methods to generate robust, consistent and inexpensive stem cells. Such companies are pointing towards a promising outlook in this regard.

Key marketed products of stem cell therapies market mentioned in this 2016 research include Prochymal (Mesoblast), Cellgram-AMI (Pharmicell), CardioRel (Reliance Life Sciences), Trinity Elite (Orthofix International), Cartistem (Medipost),  Osteocel Plus (NuVasive)  and Holoclar (Chiesi Farmaceutici). Order a copy of Stem Cell Therapies - Global Trends in the Competitive, Technological and R&D Landscape 2016 market research report at .

Converting the scientific potential of stem cell technology into real therapeutic value still represents a significant challenge, however. The stem cells field is still surrounded by a wide variety of scientific, technological, legal and ethical challenges, and suitability for commercial usage has been rather slow to attain. If stem cell therapies market is to help realize full commercial potential of stem cell technology, manufacturers will need to adopt novel and comprehensive strategies to overcome these challenges, such as those described in this report.

This research report allows you to gain insightful analyses and understanding of stem cell therapies market dynamics. This report comprehensively describes and assesses the most pertinent commercial, technological, and innovative aspects of the stem cell therapy market. Obtain an analytical review of the most important factors driving or restraining growth in the stem cell therapies market through our industry survey results, examining the relative importance of these factors. Specific challenges to successful stem cell therapy development and commercialization are therefore explored in detail and the most important drivers of growth, and opportunities in the field, are identified and discussed.

Another newly published market research report titled on "Global Stem Cell Partnering 2010-2016: Deal trends, players, financials and forecasts" provides comprehensive understanding and unprecedented access to the stem cell partnering deals and agreements entered into by the world's leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter Stem Cell partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and proceed to commercialization of outcomes. The report takes the reader through a comprehensive review Stem Cell deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Stem Cell partnering deals. The report presents financial deal term values for Stem Cell deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals. Global Stem Cell Partnering research report of 370 pages is available at .

Explore more reports on Stem Cell.

About Us: is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
Tel:  +1-888-391-5441

Connect with Us:  

G+ / Google Plus:



RSS / Feeds:

SOURCE RnR Market Research